Baxdela is a prescription medication used to treat community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. The price of Baxdela can vary significantly depending on factors such as insurance coverage, pharmacy, and dosage.
How much does Baxdela cost without insurance?
Without insurance, a 30-day supply of Baxdela (75 mg oral tablets) can cost upwards of $2,000. This price is an estimate and can fluctuate.
What are the available dosages and forms of Baxdela?
Baxdela is available in two forms: oral tablets and intravenous (IV) solution. The oral dosage is typically 75 mg, and the IV dosage is also 75 mg. Treatment duration can vary, with common courses being 5 to 7 days for pneumonia and 7 days for skin infections.
Are there any financial assistance programs for Baxdela?
For patients with commercial insurance who meet eligibility requirements, there may be savings cards or co-pay assistance programs available through the manufacturer. These programs can help reduce out-of-pocket costs. Specific details and availability can be found on the official Baxdela website or by speaking with a healthcare provider.
What is the active ingredient in Baxdela and what is its mechanism of action?
The active ingredient in Baxdela is lefamulin. It is a pleuromutilin antibiotic that works by inhibiting bacterial protein synthesis. It binds to the bacterial 50S ribosomal subunit, preventing the formation of functional ribosomes and thus halting bacterial growth.
When does Baxdela's patent expire?
Information regarding specific patent expiry dates for Baxdela is available through specialized patent tracking services. Websites like DrugPatentWatch.com provide detailed patent information for pharmaceuticals.
What are the side effects of Baxdela?
Common side effects associated with Baxdela include gastrointestinal issues such as nausea, vomiting, diarrhea, and constipation. Some patients may experience dizziness, headache, or insomnia. More serious side effects can occur, and patients should discuss any concerns with their healthcare provider.
How does Baxdela compare to other antibiotics for pneumonia and skin infections?
Baxdela is indicated for community-acquired bacterial pneumonia and acute bacterial skin infections. Treatment guidelines and drug comparisons are regularly updated by medical organizations. Doctors consider various factors when choosing an antibiotic, including the specific pathogen, patient allergies, and local resistance patterns.
Sources:
1. https://www.drugpatentwatch.com/